论文部分内容阅读
目的探讨微生态制剂治疗婴幼儿肺炎继发腹泻实际临床疗效。方法将我院收治的肺炎继发腹泻患儿104例,随机平均分为治疗组和对照组。两组患儿均按照婴幼儿肺炎防治方案进行对症治疗及应用抗生素,治疗组同时给予微生态制剂预防性治疗,对照组则在出现腹泻后方给予微生态制剂治疗。观察两组患者实际临床疗效、腹泻发生率、以及止泻效果。结果治疗组继发腹泻9例,对照组继发腹泻20例,且治疗组止泻时间2.2d,腹泻总疗程3.6d,显效6例,有效2例,无效1例,总有效率88.89%;而对照组止泻时间4.3d,腹泻总疗程6.3d,显效9例,有效4例,无效7例,总有效率65.00%。结论微生态制剂治疗婴幼儿肺炎继发腹泻临床疗效显著,且具有良好的预防作用,值得在临床推广。
Objective To explore the clinical efficacy of probiotics in the treatment of secondary diarrhea in infants with pneumonia. Methods 104 cases of children with secondary secondary diarrhea admitted to our hospital were randomly divided into treatment group and control group. Both groups of children were treated symptomatically with antibiotics according to the scheme of prevention and treatment of infantile pneumonia. The treatment group was also given prophylactic treatment of probiotics while the control group was treated with probiotics after diarrhea. The actual clinical efficacy, the incidence of diarrhea and the anti-diarrhea effect in both groups were observed. Results In the treatment group, there were 9 cases of secondary diarrhea, 20 cases of secondary diarrhea in the control group, 2.2 days of diarrhea in the treatment group and 3.6 days in the treatment group. Six cases were markedly effective, two cases were effective and one was ineffective. The total effective rate was 88.89%. The control group, diarrhea time 4.3d, the total course of diarrhea 6.3d, markedly effective in 9 cases, effective in 4 cases, 7 cases, the total effective rate was 65.00%. Conclusions The probable clinical effect of probiotics in the treatment of secondary diarrhea in infants with pneumonia is significant and has a good preventive effect, which is worthy of clinical promotion.